ABT, Abbott
Abbott’s (ABT) Impressive Q4 and Bold Projections for 2025: What You Need to Know
The company’s projected adjusted diluted EPS for 2025 is between $5.05 and $5.25, marking double-digit growth at the midpoint. Abbott’s first-quarter 2025 adjusted EPS is expected to be between $1.05 and $1.09, further underscoring its momentum heading into the new year.
Arcblock (ABT) shot up by more than 45% in the past 24 hours and claimed a daily high of $1.92, facing resistance at $2.
Mizuho Securities analyst Anthony Petrone maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday. The company’s ...
Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.
The National Investigation Agency (NIA) Special Court, Guwahati (Assam), has sentenced two accused to imprisonment in the ABT ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...
Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong ...
Seeking Alpha on MSN1d
Abbott Laboratories slips after Q4 topline missAbbott Laboratories (ABT) stock traded lower in the premarket on Wednesday after its Q4 2024 results fell short of Street ...
Abbott Laboratories ABT reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.34, in line with the Zacks ...
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...
How do I book for a repair service? Abt Electronics offers complimentary repair services for products purchased from them, valid within the first year of purchase. Please note that these repairs ...
Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback